EW HEALTHCARE PARTNERS FUND 2, L.P. - 29 Mar 2022 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role: Other*
Signature: EW HEALTHCARE PARTNERS FUND 2, L.P., By: EW Healthcare Partners Fund 2 GP, L.P., its General Partner, By: EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter
Issuer symbol: TELA
Transactions as of: 29 Mar 2022
Net transactions value: +$66,370
Form type: 4
Filing time: 31 Mar 2022, 12:01:10 UTC
Previous filing: 24 Mar 2022
Next filing: 04 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TELA	Common Stock, par value $0.001 per share	Purchase	$35,556	+3,052	+0.09%	$11.65	3,308,591	29 Mar 2022	See footnotes	F1, F2
transaction	TELA	Common Stock, par value $0.001 per share	Purchase	$30,814	+2,645	+0.08%	$11.65	3,311,236	30 Mar 2022	See footnotes	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,199 shares and 1,039 shares of the amount shown above for March 29, 2022 and March 30, 2022, respectively, and Fund 2-A purchased 1,853 shares and 1,606 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,342,034 shares and Fund 2-A now holds a total of 1,969,202 shares of the Issuer.
F2	EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Content

The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,199 shares and 1,039 shares of the amount shown above for March 29, 2022 and March 30, 2022, respectively, and Fund 2-A purchased 1,853 shares and 1,606 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,342,034 shares and Fund 2-A now holds a total of 1,969,202 shares of the Issuer.

EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.